These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

528 related articles for article (PubMed ID: 27882487)

  • 21. Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes.
    Alvarez-Erviti L; Seow Y; Yin H; Betts C; Lakhal S; Wood MJ
    Nat Biotechnol; 2011 Apr; 29(4):341-5. PubMed ID: 21423189
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro evaluation of endothelial exosomes as carriers for small interfering ribonucleic acid delivery.
    Banizs AB; Huang T; Dryden K; Berr SS; Stone JR; Nakamoto RK; Shi W; He J
    Int J Nanomedicine; 2014; 9():4223-30. PubMed ID: 25214786
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Microglia-derived HIV Nef+ exosome impairment of the blood-brain barrier is treatable by nanomedicine-based delivery of Nef peptides.
    Raymond AD; Diaz P; Chevelon S; Agudelo M; Yndart-Arias A; Ding H; Kaushik A; Jayant RD; Nikkhah-Moshaie R; Roy U; Pilakka-Kanthikeel S; Nair MP
    J Neurovirol; 2016 Apr; 22(2):129-39. PubMed ID: 26631079
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Small interfering RNA (siRNA) targeting vascular endothelial growth factor inhibits vascular leakage in brain of rats exposed to high altitude].
    Deng ZK; Qian GS; Cheng SY; Wu J
    Zhonghua Yi Xue Za Zhi; 2009 Oct; 89(37):2639-43. PubMed ID: 20137683
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exosome as a Novel Shuttle for Delivery of Therapeutics across Biological Barriers.
    Das CK; Jena BC; Banerjee I; Das S; Parekh A; Bhutia SK; Mandal M
    Mol Pharm; 2019 Jan; 16(1):24-40. PubMed ID: 30513203
    [TBL] [Abstract][Full Text] [Related]  

  • 26. RNA interference targeting hypoxia-inducible factor 1α via a novel multifunctional surfactant attenuates glioma growth in an intracranial mouse model.
    Gillespie DL; Aguirre MT; Ravichandran S; Leishman LL; Berrondo C; Gamboa JT; Wang L; King R; Wang X; Tan M; Malamas A; Lu ZR; Jensen RL
    J Neurosurg; 2015 Feb; 122(2):331-41. PubMed ID: 25423275
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibiting the growth of malignant melanoma by blocking the expression of vascular endothelial growth factor using an RNA interference approach.
    Tao J; Tu YT; Huang CZ; Feng AP; Wu Q; Lian YJ; Zhang LX; Zhang XP; Shen GX
    Br J Dermatol; 2005 Oct; 153(4):715-24. PubMed ID: 16181451
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combined delivery of BCNU and VEGF siRNA using amphiphilic peptides for glioblastoma.
    Yi N; Oh B; Kim HA; Lee M
    J Drug Target; 2014 Feb; 22(2):156-64. PubMed ID: 24219243
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intravenous siRNA of brain cancer with receptor targeting and avidin-biotin technology.
    Xia CF; Zhang Y; Zhang Y; Boado RJ; Pardridge WM
    Pharm Res; 2007 Dec; 24(12):2309-16. PubMed ID: 17926121
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-EGFR ScFv functionalized exosomes delivering LPCAT1 specific siRNAs for inhibition of lung cancer brain metastases.
    Jiang J; Lu Y; Chu J; Zhang X; Xu C; Liu S; Wan Z; Wang J; Zhang L; Liu K; Liu Z; Yang A; Ren X; Zhang R
    J Nanobiotechnology; 2024 Apr; 22(1):159. PubMed ID: 38589859
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SELEX-Based Screening of Exosome-Tropic RNA.
    Yamashita T; Shinotsuka H; Takahashi Y; Kato K; Nishikawa M; Takakura Y
    Biol Pharm Bull; 2017; 40(12):2140-2145. PubMed ID: 29199238
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Delivery of Small Interfering RNAs to Cells via Exosomes.
    Wahlgren J; Statello L; Skogberg G; Telemo E; Valadi H
    Methods Mol Biol; 2016; 1364():105-25. PubMed ID: 26472446
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Polyethylenimine/small interfering RNA-mediated knockdown of vascular endothelial growth factor in vivo exerts anti-tumor effects synergistically with Bevacizumab.
    Höbel S; Koburger I; John M; Czubayko F; Hadwiger P; Vornlocher HP; Aigner A
    J Gene Med; 2010 Mar; 12(3):287-300. PubMed ID: 20052738
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exosome-mediated small interfering RNA delivery inhibits aberrant osteoblast differentiation in Apert syndrome model mice.
    Myo AC; Kobayashi Y; Niki Y; Kamimoto H; Moriyama K
    Arch Oral Biol; 2023 Sep; 153():105753. PubMed ID: 37348363
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of Combination Therapy with MET and VEGF Inhibitors for MET-overexpressing Glioblastoma.
    Okuda T; Tasaki T; Nakata S; Yamashita K; Yoshioka H; Izumoto S; Kato A; Fujita M
    Anticancer Res; 2017 Jul; 37(7):3871-3876. PubMed ID: 28668888
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Astrocyte-Derived Pentraxin 3 Supports Blood-Brain Barrier Integrity Under Acute Phase of Stroke.
    Shindo A; Maki T; Mandeville ET; Liang AC; Egawa N; Itoh K; Itoh N; Borlongan M; Holder JC; Chuang TT; McNeish JD; Tomimoto H; Lok J; Lo EH; Arai K
    Stroke; 2016 Apr; 47(4):1094-100. PubMed ID: 26965847
    [TBL] [Abstract][Full Text] [Related]  

  • 37. WDR81 Gene Silencing Can Reduce Exosome Levels in Human U87-MG Glioblastoma Cells.
    Tadayoni Nia A; Bazi Z; Khosravi A; Oladnabi M
    J Mol Neurosci; 2021 Aug; 71(8):1696-1702. PubMed ID: 33954857
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exosomes for targeted siRNA delivery across biological barriers.
    El Andaloussi S; Lakhal S; Mäger I; Wood MJ
    Adv Drug Deliv Rev; 2013 Mar; 65(3):391-7. PubMed ID: 22921840
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A small interfering RNA targeting vascular endothelial growth factor as cancer therapeutics.
    Takei Y; Kadomatsu K; Yuzawa Y; Matsuo S; Muramatsu T
    Cancer Res; 2004 May; 64(10):3365-70. PubMed ID: 15150085
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exosomes and biomimetic nanovesicles-mediated anti-glioblastoma therapy: A head-to-head comparison.
    Wu JY; Li YJ; Hu XB; Huang S; Luo S; Tang T; Xiang DX
    J Control Release; 2021 Aug; 336():510-521. PubMed ID: 34237399
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.